Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite‐modified proteins and reactive oxygen species in Wegener's granulomatosis

To investigate the role of nitric oxide (NO) in glomerular inflammation, the expression of endothelial NO synthase (eNOS) and inducible NOS (iNOS) was studied in conjunction with inflammatory cell influx, H2O2 production, and the formation of nitrotyrosines in renal biopsies from patients with Wegener's granulomatosis (WG). Renal cryostat sections from patients with WG (n=15) were stained by immunohistochemistry for eNOS, iNOS, endothelial cells (CD31), nitrotyrosines, polymorphonuclear cells (PMNs, CD15), and monocytes/macrophages (CD14, CD68). Production of H2O2 was identified by enzyme cytochemistry using diaminobenzidine. In control tissues, strong staining for eNOS was found in glomerular and interstitial tubular capillaries and cortical vessels. A significant reduction in eNOS expression was found in WG biopsies, which was associated with a reduction in CD31 expression. Expression of iNOS was found in infiltrating inflammatory cells, mainly located in the interstitium. H2O2‐producing cells were detected in glomeruli and were abundantly present in the interstitium. Nitrotyrosine‐positive cells, however, were almost exclusively found in the interstitium. It is concluded that renal inflammation in WG is associated with the induction of iNOS in inflammatory cells and the formation of nitrotyrosines. Expression of eNOS in glomerular capillaries is lost, most likely due to endothelial cell damage. These results suggest that decreased NO⋅ production by endothelial cells, in conjunction with increased NO⋅ production by iNOS‐positive inflammatory cells, is involved in renal tissue injury in WG. Copyright © 2000 John Wiley & Sons, Ltd.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[2]  V. Cattell,et al.  Nitric oxide and glomerulonephritis. , 1999, Seminars in nephrology.

[3]  P. Sarathchandra,et al.  Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis. , 1999, The Biochemical journal.

[4]  J. Groves,et al.  Peroxynitrite: reactive, invasive and enigmatic. , 1999, Current opinion in chemical biology.

[5]  R. Radi,et al.  Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. , 1999, Journal of immunology.

[6]  L. K. Nelson,et al.  Priming of human neutrophils by peroxynitrite: potential role in enhancement of the local inflammatory response , 1999, Journal of leukocyte biology.

[7]  J. Filep,et al.  Peroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole blood. , 1998, Journal of immunology.

[8]  T. Koji,et al.  Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. , 1998, Kidney international.

[9]  V. Cattell,et al.  Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2. , 1998, Kidney international.

[10]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[11]  O. Feron,et al.  Nitric oxide synthases: which, where, how, and why? , 1997, Journal of Clinical Investigation.

[12]  M. Omata,et al.  Role of nitric oxide in rat nephrotoxic nephritis: comparison between inducible and constitutive nitric oxide synthase. , 1997, Journal of the American Society of Nephrology : JASN.

[13]  O. Carretero,et al.  ROLE OF NITRIC OXIDE IN THE CONTROL OF GLOMERULAR MICROCIRCULATINO , 1997, Clinical and experimental pharmacology & physiology.

[14]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[15]  C. Kallenberg,et al.  Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. , 1996, Kidney international.

[16]  M. Endoh,et al.  Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. , 1996, Kidney international.

[17]  V. Cattell,et al.  L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. , 1996, Kidney international.

[18]  V. Cattell,et al.  The nitric oxide pathway in glomerulonephritis , 1995, Current opinion in nephrology and hypertension.

[19]  L. Raij,et al.  Glomerular actions of nitric oxide. , 1995, Kidney international.

[20]  S. Bachmann,et al.  Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. , 1995, The American journal of physiology.

[21]  L. Raij,et al.  Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. , 1994, Kidney international.

[22]  C. Kallenberg,et al.  Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. , 1994, Kidney international.

[23]  C. Kallenberg,et al.  Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. , 1994, Kidney international.

[24]  W. Couser Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  W. Couser,et al.  Crescentic glomerulonephritis without immune deposits: clinicopathologic features. , 1979, Kidney international.

[26]  A. Gibofsky American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.

[27]  I. Narita,et al.  Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[28]  N. Avdalović,et al.  Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. , 1983, Journal of immunological methods.